15
Apr
Remedium Lifecare Limited (BSE: 539561), a fast-growing player in pharmaceutical intermediates and specialty chemicals, has received approval from the Bombay Stock Exchange (BSE) for its ₹49.19 crore rights issue. The move is aimed at raising capital from existing shareholders to fund manufacturing expansion, R&D equipment, and meet working capital needs. As per the approved terms, the issue offers 61 equity shares for every 50 fully paid-up shares held on the record date, April 15, 2025, at ₹1 per share. A total of 49.19 crore fully paid-up shares will be issued, with the face value pegged at ₹1 each. “This approval…
